Artificial Intelligence/Machine Learning Medical Device Global Market Report 2023: Sector is Expected to Reach $35.4 Billion by 2032 at a CAGR of 24.4% – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Artificial Intelligence/Machine Learning Medical Device Market – A Global and Regional Analysis: Focus on Product Type, Clinical Area, and Country Analysis – Analysis and Forecast, 2022-2032” report has been added to ResearchAndMarkets.com’s offering.

The global artificial intelligence/machine learning medical device market was valued at $4,011.7 million in 2022 and is anticipated to reach $35,458.2 million by 2032, witnessing a CAGR of 24.35% during the forecast period 2022-2032.

The market is driven by factors such as the presence of a large ecosystem of companies offering AI solutions, growing demand in the field of radiology and cardiology, growing demand for wearable sensors, and large number of government initiatives.

Market Lifecycle Stage

The global artificial intelligence/machine learning medical device market is highly fragmented, and the number of FDA and CE marked approvals of AI-enabled medical devices is increasing each year. This market still holds significant potential for growth as technological developments and investments into AI in healthcare are ongoing globally.

The opportunity for growth of the global artificial intelligence/machine learning medical device market lies in innovations in technology and the further development of AI-based medical devices enabling diagnostic accuracy and productivity.

Recent Developments in Global Artificial Intelligence/Machine Learning Medical Device Market

In October 2022, Koninklijke Philips N.V. received the U.S. FDA 510(k) approval for its AI-enabled MRCAT head and neck radiotherapy application.

In June 2022, Aidoc Medical, Ltd. raised a $110 million Series D round investment to address the challenges faced by health systems by using AI.

In June 2022, Hyperfine Inc. received FDA 510(k) clearance for the MRI device Swoop. The Swoop system software uses deep learning to deliver clear images that aid in clinical diagnosis.

In April 2022, Clarius Mobile Health Corp.’s range of ultra-portable scanners, Clarius HD, was approved by Health Canada.

In March 2022, Clarius Mobile Health Corp. raised $20.0 million in funding to expand its commercial-scale activities.

Demand – Drivers and Limitations

The following are the drivers for the global artificial intelligence/machine learning medical device market:

Presence of a Large Ecosystem of Companies Offering AI Solutions Targeting the Diverse Range of Applications of AI in the Healthcare

Growing Demand in the Field of Radiology and Cardiology Increasing Adoption of AI-Enabled Solutions due to Their Ability to Shorten Waiting Times and Reduce Burden on Healthcare System

Growing Demand for Wearable Sensors to Increase Adoption of AI-Enabled Medical Devices for Home-Based Care

Large Number of Government Initiatives Advancing the Research and Development of AI-Enabled Medical Devices

The market is expected to face some limitations as well due to the following challenges:

Lack of Transparency and Concerns around Data Sharing Leading to Cybersecurity Concerns and Hindering Adoption of AI in Healthcare

Challenges Related to Identification and Minimization of Bias in AI Algorithms Leading to Concerns Surrounding the Reliability of Diagnosis and Thus Hindering the Use of AI-Enabled Solutions

Key Attributes:

Report Attribute
Details

No. of Pages
208

Forecast Period
2022 – 2032

Estimated Market Value (USD) in 2022
$4011.7 Million

Forecasted Market Value (USD) by 2032
$35458.2 Million

Compound Annual Growth Rate
24.4%

Regions Covered
Global

Key Companies Profiled

Aidoc Medical, Ltd.

Canon Inc.

CellaVision AB

Clarius Mobile Health Corp.

General Electric Company

Hyperfine Inc.

Koninklijke Philips N.V.

Medtronic plc

Nanox.AI Ltd.

Paige.AI

RadNet, Inc.

Shanghai United Imaging Healthcare Co., Ltd.

Siemens Healthineers AG

Tempus

Viz.ai, Inc.

Market Segmentation

Segmentation 1: by Product Type

System/Hardware

Software-as-a-Medical Device

The global artificial intelligence/machine learning medical device market (by product type) is expected to be dominated by the software-as-a-medical device segment.

Segmentation 2: by Clinical Area

Radiology

Cardiology

Hematology

Others

The global artificial intelligence/machine learning medical device market (by clinical area) is expected to be dominated by the radiology segment.

Segmentation 3: Radiology (by Type)

Diagnostic Assistance

Imaging

Image Reconstruction

Others

The global radiology artificial intelligence/machine learning medical device market (by type) is expected to be dominated by the diagnostic assistance segment.

Segmentation 4: Cardiology (by Type)

Electrocardiography-Based Arrhythmia Detection

Hemodynamics and Vital Signs Monitoring

Others

The global cardiology artificial intelligence/machine learning medical device market (by type) is expected to be dominated by the electrocardiography-based arrhythmia detection segment.

Segmentation 5: by Region

North America – U.S., Canada

Europe – Germany, U.K., France, Italy, Spain, and Rest-of-Europe

Asia-Pacific – China, Japan, India, Australia, South Korea, and Rest-of-Asia-Pacific

Rest-of-the-World – Brazil, Mexico, Israel, and Rest-of-Rest-of-the-World

The global artificial intelligence/machine learning medical device market (by region) is dominated by the North America region.

For more information about this report visit https://www.researchandmarkets.com/r/vstst3

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]
For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Subscribe on LinkedIn

Get the free newsletter

Subscribe to MedicaEx for top news, trends & analysis

We're committed to your privacy. MedicaEx uses the information you provide to us to contact you about our relevant content, products, and services. You may unsubscribe from these communications at any time. For more information, check out our Privacy Policy.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Businesswire is solely responsible for the content of the above news submissions. If there are any violations of laws, violations of the membership terms of this website, or the risk of infringing on the rights of third parties, businesswire will be solely responsible for legal and damage compensation. Responsibility has nothing to do with MedicaEx.

Are you in?

Subscribe to receive exclusive content and notifications to your inbox

We're committed to your privacy. MedicaEx uses the information you provide to us to contact you about our relevant content, products, and services. You may unsubscribe from these communications at any time. For more information, check out our Privacy Policy.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.